Calumet Specialty Products Partners Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calumet Specialty Products Partners in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Calumet Specialty Products Partners stock.
View analyst ratings for Calumet Specialty Products Partners or view top-rated stocks.

Wall Street analysts have given Calumet Specialty Products Partners a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Calumet Specialty Products Partners wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Calumet Specialty Products Partners saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 84,800 shares, an increase of 26.2% from the June 15th total of 67,200 shares. Based on an average daily volume of 129,200 shares, the short-interest ratio is currently 0.7 days. Currently, 0.1% of the company's stock are short sold.
View Calumet Specialty Products Partners' Short Interest.

Calumet Specialty Products Partners is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Calumet Specialty Products Partners.

Calumet Specialty Products Partners will be holding an earnings conference call on Friday, August 6th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) issued its quarterly earnings data on Friday, May, 7th. The oil and gas company reported ($1.82) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.85) by $0.97. The oil and gas company had revenue of $600.30 million for the quarter, compared to analyst estimates of $586.20 million.
View Calumet Specialty Products Partners' earnings history.

Calumet Specialty Products Partners' stock was trading at $2.23 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLMT stock has increased by 199.6% and is now trading at $6.68.
View which stocks have been most impacted by COVID-19.

1 brokers have issued 1 year price targets for Calumet Specialty Products Partners' stock. Their forecasts range from $8.00 to $8.00. On average, they anticipate Calumet Specialty Products Partners' share price to reach $8.00 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts' price targets for Calumet Specialty Products Partners or view top-rated stocks among Wall Street analysts.

18 employees have rated Calumet Specialty Products Partners CEO Tim Go on Glassdoor.com. Tim Go has an approval rating of 42% among Calumet Specialty Products Partners' employees. This puts Tim Go in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Calumet Specialty Products Partners include YPF Sociedad Anónima (YPF), CVR Energy (CVI), Delek US (DK), PBF Energy (PBF), Vertex Energy (VTNR), Trecora Resources (TREC), BP Prudhoe Bay Royalty Trust (BPT) and Green Planet Group (GNPG).
View all of CLMT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Calumet Specialty Products Partners investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Summit Midstream Partners (SMLP), Viper Energy Partners (VNOM), Washington Prime Group (WPG), Roper Technologies (ROP) and New Residential Investment (NRZ).

Calumet Specialty Products Partners trades on the NASDAQ under the ticker symbol "CLMT."

Calumet Specialty Products Partners' stock is owned by many different retail and institutional investors. Top institutional investors include Stratos Wealth Partners LTD. (0.03%).
View institutional ownership trends for Calumet Specialty Products Partners.

CLMT stock was purchased by a variety of institutional investors in the last quarter, including Stratos Wealth Partners LTD..
View insider buying and selling activity for Calumet Specialty Products Partners or or view top insider-buying stocks.

Shares of CLMT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLMT stock can currently be purchased for approximately $6.68.

Calumet Specialty Products Partners has a market capitalization of $525.56 million and generates $2.27 billion in revenue each year. The oil and gas company earns $-149,000,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis.

Calumet Specialty Products Partners employs 1,400 workers across the globe.

The official website for Calumet Specialty Products Partners is www.calumetspecialty.com.

Calumet Specialty Products Partners is headquartered at 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214.

Calumet Specialty Products Partners' mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The oil and gas company can be reached via phone at (317) 328-5660 or via email at [email protected]